MedPath

Comparison of two devices Proseal LMA and Ambu Auragain LMA in laparoscopic cholecystectomy for anaesthesia

Phase 4
Conditions
Health Condition 1: null- ASA ( American society of Anaesthesiologist) grade 1 and 2Health Condition 2: K819- Cholecystitis, unspecified
Registration Number
CTRI/2018/10/016085
Lead Sponsor
AIIMS Raipur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.ASA physical status grade I and II

2.Patients of either sex

3.18 â?? 65 years of age

4.BMI â?? 18.5 â?? 30

5.Patients undergoing laparoscopic cholecystectomy under general anaesthesia (1-2 hours duration)

Exclusion Criteria

1.Restricted mouth opening ( < 2.5cm)

2.Mallampati Grade (MPG) III/IV

3.Patients with airway morbidities (Respiratory tract infections, COPD etc)

4.Patients with BMI >30

5.Patients with risk of gastric aspiration (non-fasted, GERD)

6.Pregnant patients

7.Patient refusal

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Maximum airway sealing pressuresTimepoint: after putting the LMA, <br/ ><br>5 minutes after carboperitonium, <br/ ><br>Before removal of LMA
Secondary Outcome Measures
NameTimeMethod
2.Ease of insertion <br/ ><br>3.Insertion Time (in seconds) <br/ ><br>4.Number of attempts <br/ ><br>5.Minimum cuff volume and pressure required to prevent leak <br/ ><br>6.Peak and plateau airway pressure <br/ ><br>7.Ease and size of gastric tube placement <br/ ><br>8.Post-operative complicationsTimepoint: Introp and Post op upto 24 hrs
© Copyright 2025. All Rights Reserved by MedPath